Advertisement
The average annual premiums for single and family coverage remained stable in 2016

Average Premiums for Health Care Coverage Stable in 2016

0
Family premium 3 percent higher in 2016 than 2015; no change in share of firms offering health benefits
Interleukin-32 has inflammatory and remodeling properties in human obesity

IL-32 Has Inflammatory Properties in Human Obesity

0
Increased circulating IL-32 in obese patients down after Roux-en-Y gastric bypass-linked weight loss
Women who consume high amounts of meat

Fatty Acid Consumption Tied to T2DM Risk in Women

0
Findings for arachidonic acid, docosapentaenoic acid, and alpha-linolenic acid
Pokémon GO is becoming a dangerous distraction for drivers

Playing Pokémon GO Leading to Increase in Distracted Driving

0
At least 14 crashes linked to the smartphone game during a 10-day period in July
A new sound-based therapy appears to reduce blood pressure and ease migraine symptoms

Sound-Based Therapy Can Reduce Blood Pressure, Ease Migraine

0
Sound therapy balances brain signals, researcher says
For American-Indians with type 2 diabetes

Early Rx With Losartan Doesn’t Slow Kidney Disease Progression

0
Findings in American-Indians with type 2 diabetes and urine albumin/creatinine ratio <300 mg/g
Advising patients with asthma to take probiotics does not reduce antibiotic use

Recommending Oral Probiotics Doesn’t Cut Antibiotic Use

0
Advice to take probiotics has no effect for patients with asthma in U.K. primary care setting
For patients with chronic chilblains

Nifedipine Not Superior to Placebo for Chronic Chilblains

0
No significant improvements in mean visual analogue scale scores on complaints, disability
For hypogonadal men with prostate cancer

Testosterone Seems Safe for Hypogonadal Prostate CA Patients

0
Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
For patients with or without dysglycemia or metabolic syndrome

Evolocumab Safe, Effective for Those With Dysglycemia, MetS

0
Reduction in LDL-C in all subgroups, including those with, without dysglycemia and metabolic syndrome